Active TB drug-safety monitoring and management (aDSM)
11 August 2015
| Publication

Overview
Adverse drug reactions can lead to a tuberculosis (TB) patient interrupting treatment before completion, and can thus contribute to avoidable morbidity, drug-resistance, treatment failure, reduced quality of life, or even death.
WHO Team
Global Programme on Tuberculosis and Lung Health (GTB)
Number of pages
2